Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Japanese Honeysuckle (Lonicera japonica) has a long history of use in traditional Chinese medicine (TCM), particularly as an ingredient in formulas that address "heat" and "toxicity"—concepts roughly analogous to infection and inflammation. In modern research, Japanese Honeysuckle flowers and extracts have demonstrated antimicrobial effects in laboratory (in vitro) studies against a range of bacteria, including Staphylococcus aureus and Escherichia coli. The active compounds, such as chlorogenic acid and luteolin, are believed to contribute to these effects. However, while these laboratory studies show promise, there is a lack of robust clinical evidence demonstrating that Japanese Honeysuckle can effectively treat bacterial infections in humans or serve as a stand-alone alternative to antibiotics. Most available clinical trials combine honeysuckle with other herbs, making it hard to isolate its specific effects. As a result, while there is some scientific basis—in vitro and in animal studies—for its antimicrobial properties, its use as an alternative or adjunct to conventional antibiotics in humans is not strongly supported by high-quality clinical data. Thus, the evidence is rated as limited (2/5).

More about Japanese Honeysuckle
More about Antibiotics (alternatives to)

Other ingredients used for Antibiotics (alternatives to)

Other health conditions supported by Japanese Honeysuckle

Products containing Japanese Honeysuckle